dipyridamole has been researched along with von Willebrand Diseases in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
von Willebrand Diseases: Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morin, RJ | 1 |
| Chen, AF | 1 |
| Narayanan, AS | 1 |
| Raye, C | 1 |
| Moss, RA | 1 |
| Srikantaiah, MV | 1 |
| Barajas, L | 1 |
| Friedman, RJ | 1 |
| Burns, ER | 1 |
1 review available for dipyridamole and von Willebrand Diseases
| Article | Year |
|---|---|
Role of platelets in the proliferative response of the injured artery.
Topics: Animals; Arteries; Arteriosclerosis; Blood Platelets; Cell Differentiation; Cell Survival; Dipyridam | 1978 |
1 other study available for dipyridamole and von Willebrand Diseases
| Article | Year |
|---|---|
Platelet adhesion to collagen in normal and von Willebrand's disease subjects.
Topics: Animals; Aspirin; Blood Platelets; Collagen; Diabetes Mellitus; Dipyridamole; Factor VIII; Humans; K | 1980 |